HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.

Other languages Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Equities

300255

CNE1000016C2

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
11.2 ^CNY	+0.09%		-7.44%	-13.91%

Apr. 28	Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 14	Yang Minghuan completed the acquisition of 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 28
Yang Minghuan completed the acquisition of 5.8% stake in Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from Gao Shuhua.	Mar. 13
Hebei Changshan Biomedical Pharma's Controlling Shareholder to Sell 5.8% Company Stake	Feb. 23
Changshan Biochemical Pharmaceutical, Unit Get Nod to Trial Tumor Drug	Jan. 09
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24
Changshan Biochemical Pharmaceutical Gets Nod to Register Deep Vein Thrombosis Drug in Lebanon	23-10-19
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30
Changshan Biochemical Pharma Registers Enoxaparin Sodium Injection in Nicaragua	23-06-15
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2022, Payable on June 27, 2023	23-05-17
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-04-24
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21
Changshan Biochemical Pharma’s Deep Vein Thrombosis Drug Shortlisted For China’s Drug Procurement Program	23-03-30
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27
Changshan Biochemical Wins Nod to Register Vein Thrombosis Drug in Turkmenistan	22-10-04
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date Is 02 June 2022	22-05-25
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year 2021	22-05-12
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Proposes Cash Dividend for the Year 2021	22-04-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Equities

300255

CNE1000016C2

Other languages

Filters